Urokinase plasminogen activator and prognosis in breast cancer - PubMed (original) (raw)

Urokinase plasminogen activator and prognosis in breast cancer

M J Duffy et al. Lancet. 1990.

No abstract available

PubMed Disclaimer

Similar articles

• Prognostic value of the urokinase-type plasminogen activator, and its inhibitors and receptor in breast cancer patients.
  Borstnar S, Vrhovec I, Svetic B, Cufer T. Borstnar S, et al. Clin Breast Cancer. 2002 Jun;3(2):138-46. doi: 10.3816/CBC.2002.n.018. Clin Breast Cancer. 2002. PMID: 12123538
• Urokinase-plasminogen activator, a marker for aggressive breast carcinomas. Preliminary report.
  Duffy MJ, O'Grady P, Devaney D, O'Siorain L, Fennelly JJ, Lijnen HJ. Duffy MJ, et al. Cancer. 1988 Aug 1;62(3):531-3. doi: 10.1002/1097-0142(19880801)62:3<531::aid-cncr2820620315>3.0.co;2-b. Cancer. 1988. PMID: 3134120
• [Molecular biology of the fibrinolytic system].
  Sumi Y. Sumi Y. Nihon Rinsho. 1987 Dec;45(12):2965-70. Nihon Rinsho. 1987. PMID: 3128676 Japanese. No abstract available.
• Plasminogen activators and cancer.
  Duffy MJ. Duffy MJ. Blood Coagul Fibrinolysis. 1990 Dec;1(6):681-7. Blood Coagul Fibrinolysis. 1990. PMID: 2133247 Review.

Cited by

• uPA and PAI-1 as biomarkers in breast cancer: validated for clinical use in level-of-evidence-1 studies.
  Duffy MJ, McGowan PM, Harbeck N, Thomssen C, Schmitt M. Duffy MJ, et al. Breast Cancer Res. 2014 Aug 22;16(4):428. doi: 10.1186/s13058-014-0428-4. Breast Cancer Res. 2014. PMID: 25677449 Free PMC article. Review.
• The plasminogen-plasmin system in malignancy.
  Kwaan HC. Kwaan HC. Cancer Metastasis Rev. 1992 Nov;11(3-4):291-311. doi: 10.1007/BF01307184. Cancer Metastasis Rev. 1992. PMID: 1423820 Review.
• Urokinase (uPA) and its inhibitor PAI-1 are strong and independent prognostic factors in node-negative breast cancer.
  Jänicke F, Schmitt M, Pache L, Ulm K, Harbeck N, Höfler H, Graeff H. Jänicke F, et al. Breast Cancer Res Treat. 1993;24(3):195-208. doi: 10.1007/BF01833260. Breast Cancer Res Treat. 1993. PMID: 8435475
• The effect of antisense inhibition of urokinase receptor in human squamous cell carcinoma on malignancy.
  Kook YH, Adamski J, Zelent A, Ossowski L. Kook YH, et al. EMBO J. 1994 Sep 1;13(17):3983-91. doi: 10.1002/j.1460-2075.1994.tb06714.x. EMBO J. 1994. PMID: 8076594 Free PMC article.
• Plasminogen activator system, vascular endothelial growth factor, and colorectal cancer progression.
  Baker EA, Bergin FG, Leaper DJ. Baker EA, et al. Mol Pathol. 2000 Dec;53(6):307-12. doi: 10.1136/mp.53.6.307. Mol Pathol. 2000. PMID: 11193049 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Elsevier Science

• Medical

  • MedlinePlus Health Information